vs
Organogenesis Holdings Inc.（ORGO）与BRC Group Holdings, Inc.（RILY）财务数据对比。点击上方公司名可切换其他公司
Organogenesis Holdings Inc.的季度营收约是BRC Group Holdings, Inc.的1.2倍（$225.6M vs $188.3M），BRC Group Holdings, Inc.净利率更高（47.9% vs 19.4%，领先28.6%），Organogenesis Holdings Inc.同比增速更快（78.1% vs -21.9%），过去两年Organogenesis Holdings Inc.的营收复合增速更高（43.2% vs -15.4%）
Organogenesis Holdings Inc.是一家领先的再生医学企业，专注于开发、生产用于伤口护理、外科修复、运动医学和皮肤病领域的先进治疗产品，主要服务美国及部分国际市场的医疗机构与患者，提供经临床验证的医疗解决方案。
ORGO vs RILY — 直观对比
营收规模更大
ORGO
是对方的1.2倍
$188.3M
营收增速更快
ORGO
高出100.0%
-21.9%
净利率更高
RILY
高出28.6%
19.4%
两年增速更快
ORGO
近两年复合增速
-15.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $225.6M | $188.3M |
| 净利润 | $43.7M | $90.3M |
| 毛利率 | — | 79.5% |
| 营业利润率 | 28.1% | 32.3% |
| 净利率 | 19.4% | 47.9% |
| 营收同比 | 78.1% | -21.9% |
| 净利润同比 | 469.5% | 1710.8% |
| 每股收益（稀释后） | $0.31 | $2.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ORGORILY
| Q4 25 | $225.6M | $188.3M | ||
| Q3 25 | $150.9M | $215.3M | ||
| Q2 25 | $101.0M | $188.2M | ||
| Q1 25 | $86.7M | $197.2M | ||
| Q4 24 | $126.7M | $241.0M | ||
| Q3 24 | $115.2M | $225.5M | ||
| Q2 24 | $130.2M | $256.0M | ||
| Q1 24 | $110.0M | $263.4M |
净利润ORGORILY
| Q4 25 | $43.7M | $90.3M | ||
| Q3 25 | $21.6M | $91.1M | ||
| Q2 25 | $-9.4M | $139.5M | ||
| Q1 25 | $-18.8M | $-10.0M | ||
| Q4 24 | $7.7M | $-5.6M | ||
| Q3 24 | $12.3M | $-284.4M | ||
| Q2 24 | $-17.0M | $-433.6M | ||
| Q1 24 | $-2.1M | $-49.2M |
毛利率ORGORILY
| Q4 25 | — | 79.5% | ||
| Q3 25 | — | 83.7% | ||
| Q2 25 | — | 81.3% | ||
| Q1 25 | 72.6% | 81.4% | ||
| Q4 24 | 75.5% | 79.8% | ||
| Q3 24 | 76.7% | 82.1% | ||
| Q2 24 | 77.6% | 84.5% | ||
| Q1 24 | 73.9% | 85.3% |
营业利润率ORGORILY
| Q4 25 | 28.1% | 32.3% | ||
| Q3 25 | 13.7% | 30.4% | ||
| Q2 25 | -12.5% | 5.7% | ||
| Q1 25 | -30.9% | -31.2% | ||
| Q4 24 | 8.1% | -69.2% | ||
| Q3 24 | 5.4% | -36.4% | ||
| Q2 24 | -10.7% | -90.8% | ||
| Q1 24 | -3.5% | -6.1% |
净利率ORGORILY
| Q4 25 | 19.4% | 47.9% | ||
| Q3 25 | 14.3% | 42.3% | ||
| Q2 25 | -9.3% | 74.1% | ||
| Q1 25 | -21.7% | -5.1% | ||
| Q4 24 | 6.1% | -2.3% | ||
| Q3 24 | 10.7% | -126.1% | ||
| Q2 24 | -13.1% | -169.4% | ||
| Q1 24 | -1.9% | -18.7% |
每股收益（稀释后）ORGORILY
| Q4 25 | $0.31 | $2.78 | ||
| Q3 25 | $0.11 | $2.91 | ||
| Q2 25 | $-0.10 | $4.50 | ||
| Q1 25 | $-0.17 | $-0.39 | ||
| Q4 24 | $0.05 | $-0.01 | ||
| Q3 24 | $0.09 | $-9.39 | ||
| Q2 24 | $-0.13 | $-14.35 | ||
| Q1 24 | $-0.02 | $-1.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $93.7M | $226.6M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $300.1M | $-171.5M |
| 总资产 | $598.7M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ORGORILY
| Q4 25 | $93.7M | $226.6M | ||
| Q3 25 | $63.7M | $184.2M | ||
| Q2 25 | $73.1M | $267.4M | ||
| Q1 25 | $110.0M | $138.3M | ||
| Q4 24 | $135.6M | $146.9M | ||
| Q3 24 | $94.3M | $159.2M | ||
| Q2 24 | $89.9M | $236.9M | ||
| Q1 24 | $88.6M | $190.7M |
总债务ORGORILY
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | $62.3M | — | ||
| Q2 24 | $63.8M | — | ||
| Q1 24 | $65.2M | — |
股东权益ORGORILY
| Q4 25 | $300.1M | $-171.5M | ||
| Q3 25 | $255.1M | $-260.5M | ||
| Q2 25 | $233.2M | $-351.7M | ||
| Q1 25 | $242.9M | $-496.8M | ||
| Q4 24 | $262.9M | $-488.2M | ||
| Q3 24 | $278.5M | $-497.6M | ||
| Q2 24 | $263.5M | $-218.3M | ||
| Q1 24 | $278.0M | $228.4M |
总资产ORGORILY
| Q4 25 | $598.7M | $1.7B | ||
| Q3 25 | $509.8M | $1.7B | ||
| Q2 25 | $461.1M | $1.5B | ||
| Q1 25 | $467.4M | $1.5B | ||
| Q4 24 | $497.9M | $1.8B | ||
| Q3 24 | $446.3M | $2.2B | ||
| Q2 24 | $443.2M | $3.2B | ||
| Q1 24 | $458.5M | $5.0B |
负债/权益比ORGORILY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.22× | — | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | 0.23× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $39.4M | $26.2M |
| 自由现金流经营现金流 - 资本支出 | $34.8M | — |
| 自由现金流率自由现金流/营收 | 15.4% | — |
| 资本支出强度资本支出/营收 | 2.1% | — |
| 现金转化率经营现金流/净利润 | 0.90× | 0.29× |
| 过去12个月自由现金流最近4个季度 | $-24.5M | — |
8季度趋势，按日历期对齐
经营现金流ORGORILY
| Q4 25 | $39.4M | $26.2M | ||
| Q3 25 | $3.1M | $-60.6M | ||
| Q2 25 | $-32.9M | $-25.6M | ||
| Q1 25 | $-19.9M | $184.0K | ||
| Q4 24 | $10.9M | $-2.7M | ||
| Q3 24 | $8.7M | $19.5M | ||
| Q2 24 | $4.7M | $111.5M | ||
| Q1 24 | $-10.2M | $135.4M |
自由现金流ORGORILY
| Q4 25 | $34.8M | — | ||
| Q3 25 | $844.0K | — | ||
| Q2 25 | $-36.5M | — | ||
| Q1 25 | $-23.6M | — | ||
| Q4 24 | $7.6M | — | ||
| Q3 24 | $6.1M | — | ||
| Q2 24 | $2.9M | — | ||
| Q1 24 | $-12.4M | — |
自由现金流率ORGORILY
| Q4 25 | 15.4% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | -36.1% | — | ||
| Q1 25 | -27.2% | — | ||
| Q4 24 | 6.0% | — | ||
| Q3 24 | 5.3% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | -11.3% | — |
资本支出强度ORGORILY
| Q4 25 | 2.1% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 3.6% | — | ||
| Q1 25 | 4.2% | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 2.0% | — |
现金转化率ORGORILY
| Q4 25 | 0.90× | 0.29× | ||
| Q3 25 | 0.14× | -0.66× | ||
| Q2 25 | — | -0.18× | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.43× | — | ||
| Q3 24 | 0.71× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ORGO
暂无分部数据
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
